Unknown PHASE3 INTERVENTIONAL 2-arm NCT04461379

Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers

Prevention, Efficacy and Safety of BCG Vaccine in COVID-19- Randomized Clinical Trial

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez

Conditions BCG COVID-19 Corona Virus Infection SARS-CoV2

Updated 7 times since 2020 Last updated: Nov 12, 2020 Started: Jul 21, 2020 Primary completion: Jan 1, 2021 Completion: Jan 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on BCG and COVID-19, this trial is ongoing. The trial is conducted by Hospital Universitario Dr. Jose E. Gonzalez and has accumulated 7 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Dec 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Active Not Recruiting PHASE3
Dec 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Oct 2020 — Dec 2020 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Aug 2020 — Oct 2020 [monthly]

Not Yet Recruiting PHASE3

First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario Dr. Jose E. Gonzalez

Data source: Hospital Universitario Dr. Jose E. Gonzalez

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Monterrey, Mexico